Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update
Introduction Underreporting is a major limitation of the voluntary reporting system of adverse
drug reactions (ADRs). A 2009 systematic review showed the knowledge and attitudes of …
drug reactions (ADRs). A 2009 systematic review showed the knowledge and attitudes of …
The effects of on‐screen, point of care computer reminders on processes and outcomes of care
Background The opportunity to improve care by delivering decision support to clinicians at
the point of care represents one of the main incentives for implementing sophisticated …
the point of care represents one of the main incentives for implementing sophisticated …
What maximizes the effectiveness and implementation of technology-based interventions to support healthcare professional practice? A systematic literature review
Background Technological support may be crucial in optimizing healthcare professional
practice and improving patient outcomes. A focus on electronic health records has left other …
practice and improving patient outcomes. A focus on electronic health records has left other …
Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis
Introduction The aim of this study was to evaluate the effectiveness of interventions used for
improving ADR reporting by patients and healthcare professionals. Areas covered A …
improving ADR reporting by patients and healthcare professionals. Areas covered A …
How to promote adverse drug reaction reports using information systems–a systematic review and meta-analysis
I Ribeiro-Vaz, AM Silva, C Costa Santos… - BMC Medical Informatics …, 2016 - Springer
Abstract Background Adverse drug reactions (ADRs) are a well-recognized public health
problem and a major cause of death and hospitalization in developed countries. The safety …
problem and a major cause of death and hospitalization in developed countries. The safety …
A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting
Introduction Adverse drug reaction (ADR) under-reporting is highly prevalent internationally
and interventions created to address this problem have only been temporarily successful …
and interventions created to address this problem have only been temporarily successful …
Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South …
HM Haines, JC Meyer, RS Summers… - European journal of …, 2020 - Springer
Abstract Purpose Adverse drug reactions (ADRs) have an appreciable impact on patients'
health. Little is known however about ADR reporting in ambulatory care environments …
health. Little is known however about ADR reporting in ambulatory care environments …
Interventions to improve adverse drug reaction reporting: a sco** review
Purpose Underreporting is the major limitation of a voluntary adverse drug reaction (ADR)
reporting system. Many studies have assessed the effectiveness of different interventions …
reporting system. Many studies have assessed the effectiveness of different interventions …
Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: a systematic review
Background Various strategies have been studied in the literature to address the significant
underreporting of adverse drug reactions (ADRs) in healthcare systems worldwide …
underreporting of adverse drug reactions (ADRs) in healthcare systems worldwide …
Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions
Pharmacovigilance is a practice aimed to monitor drug safety in real life conditions and
capture adverse drug events during the post marketing phase of drug's life cycle. But under …
capture adverse drug events during the post marketing phase of drug's life cycle. But under …